China · Delayed Price · Currency is CNY Sinocare Statistics
Total Valuation
Sinocare has a market cap or net worth of CNY 9.05 billion. The enterprise value is 9.31 billion.
| Market Cap | 9.05B |
| Enterprise Value | 9.31B |
Important Dates
The next confirmed earnings date is Tuesday, August 4, 2026.
| Earnings Date | Aug 4, 2026 |
| Ex-Dividend Date | Jun 13, 2025 |
Share Statistics
Sinocare has 546.53 million shares outstanding. The number of shares has decreased by -1.73% in one year.
| Current Share Class | 546.53M |
| Shares Outstanding | 546.53M |
| Shares Change (YoY) | -1.73% |
| Shares Change (QoQ) | -0.86% |
| Owned by Insiders (%) | 51.08% |
| Owned by Institutions (%) | 13.14% |
| Float | 261.81M |
Valuation Ratios
The trailing PE ratio is 67.46 and the forward PE ratio is 22.23.
| PE Ratio | 67.46 |
| Forward PE | 22.23 |
| PS Ratio | 1.83 |
| PB Ratio | 2.66 |
| P/TBV Ratio | 4.76 |
| P/FCF Ratio | 21.28 |
| P/OCF Ratio | 15.89 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.38, with an EV/FCF ratio of 21.91.
| EV / Earnings | 69.86 |
| EV / Sales | 1.89 |
| EV / EBITDA | 19.38 |
| EV / EBIT | 29.28 |
| EV / FCF | 21.91 |
Financial Position
The company has a current ratio of 1.23, with a Debt / Equity ratio of 0.29.
| Current Ratio | 1.23 |
| Quick Ratio | 0.79 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | 2.02 |
| Debt / FCF | 2.29 |
| Interest Coverage | 8.18 |
Financial Efficiency
Return on equity (ROE) is 1.86% and return on invested capital (ROIC) is 4.67%.
| Return on Equity (ROE) | 1.86% |
| Return on Assets (ROA) | 3.32% |
| Return on Invested Capital (ROIC) | 4.67% |
| Return on Capital Employed (ROCE) | 8.14% |
| Weighted Average Cost of Capital (WACC) | 3.44% |
| Revenue Per Employee | 984,572 |
| Profits Per Employee | 26,613 |
| Employee Count | 5,010 |
| Asset Turnover | 0.82 |
| Inventory Turnover | 3.48 |
Taxes
In the past 12 months, Sinocare has paid 68.70 million in taxes.
| Income Tax | 68.70M |
| Effective Tax Rate | 50.74% |
Stock Price Statistics
The stock price has decreased by -21.53% in the last 52 weeks. The beta is -0.12, so Sinocare's price volatility has been lower than the market average.
| Beta (5Y) | -0.12 |
| 52-Week Price Change | -21.53% |
| 50-Day Moving Average | 15.06 |
| 200-Day Moving Average | 16.94 |
| Relative Strength Index (RSI) | 66.49 |
| Average Volume (20 Days) | 8,436,341 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sinocare had revenue of CNY 4.93 billion and earned 133.33 million in profits. Earnings per share was 0.25.
| Revenue | 4.93B |
| Gross Profit | 2.41B |
| Operating Income | 318.10M |
| Pretax Income | 135.38M |
| Net Income | 133.33M |
| EBITDA | 468.22M |
| EBIT | 318.10M |
| Earnings Per Share (EPS) | 0.25 |
Balance Sheet
The company has 1.02 billion in cash and 972.57 million in debt, with a net cash position of 43.68 million or 0.08 per share.
| Cash & Cash Equivalents | 1.02B |
| Total Debt | 972.57M |
| Net Cash | 43.68M |
| Net Cash Per Share | 0.08 |
| Equity (Book Value) | 3.39B |
| Book Value Per Share | 5.73 |
| Working Capital | 472.61M |
Cash Flow
In the last 12 months, operating cash flow was 569.27 million and capital expenditures -144.15 million, giving a free cash flow of 425.12 million.
| Operating Cash Flow | 569.27M |
| Capital Expenditures | -144.15M |
| Depreciation & Amortization | 150.12M |
| Net Borrowing | 158.83M |
| Free Cash Flow | 425.12M |
| FCF Per Share | 0.78 |
Margins
Gross margin is 48.89%, with operating and profit margins of 6.45% and 2.70%.
| Gross Margin | 48.89% |
| Operating Margin | 6.45% |
| Pretax Margin | 2.74% |
| Profit Margin | 2.70% |
| EBITDA Margin | 9.49% |
| EBIT Margin | 6.45% |
| FCF Margin | 8.62% |
Dividends & Yields
This stock pays an annual dividend of 0.22, which amounts to a dividend yield of 1.33%.
| Dividend Per Share | 0.22 |
| Dividend Yield | 1.33% |
| Dividend Growth (YoY) | 10.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 12.56% |
| Buyback Yield | 1.73% |
| Shareholder Yield | 3.06% |
| Earnings Yield | 1.47% |
| FCF Yield | 4.70% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Sinocare is 22.88, which is 41.41% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 22.88 |
| Price Target Difference | 41.41% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 9.77% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on July 16, 2018. It was a forward split with a ratio of 1.2.
| Last Split Date | Jul 16, 2018 |
| Split Type | Forward |
| Split Ratio | 1.2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |